Gaoma therapeutics logo

Author: ylgh

August undefined, 2024

WebInvestors of Gaoma Therapeutics include Health Angels Rhone-Alpes, Angels Sante, PPRS Venture and Simba Sante. Discover the right solution for your team The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Webgaoma-tx.com : Contact Email: [email protected]: GAOMA Therapeutics industries Pharma: Headquarters Location: 59, Boulevard Pinel, Bron, Auvergne-Rhone-Alpes, 69500 FR 59, Boulevard Pinel, Bron, ... GAOMA Therapeutics Employees Size 1 …

gaoma-therapeutics.com domain info (Gao Ma Therapeutics)

WebAug 9, 2024 · In the past 5 years, W.L. has received consultancy fees from Lundbeck, AC Immune, Clexio Biosciences, and Pragma Therapeutics, and has served on the advisory board of Angelini Pharma. P.B.-F. was an employee of Grünenthal (Aachen, Germany). WebGAOMA Therapeutics janv. 2024 - janv. 2024 1 an 1 mois. Bron, Auvergne-Rhône-Alpes, France (CDD - voir recommandation donnée par le CEO, Jordan GUYON) ... Conseil stratégique et accompagnement en communication de groupes musicaux (logos, … rake cast 2018

Pipeline - Gaoma Therapeutics

WebGAOMA Therapeutics information. GAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under-exploited, whereas it plays a key role in many medical conditions. GAOMA has the ambition to tap into the therapeutic ... WebDIGITAL RESI - JUNE 2024 GAOMA Therapeutics will attend the digital RESI convention on June 7-9, 2024. Our team members will be pleased to meet with you and… WebScientific Advisory Board. Our SAB brings together advisors at the international level, providing GAOMA with a sharp medical and scientific expertise in its fields of operations. Prof. Emilio PERUCCA. MD, PhD. Prof. Sylvain RHEIMS. MD, PhD. Prof. Yusuf HANNUN. MD. Prof. Daniel HOYER. dr. godine mgh

gaoma-therapeutics.com domain info (Gao Ma Therapeutics)

Gaoma Therapeutics - Headquarters Locations, Products, …

WebCOMPANY OVERVIEW. GAOMA is a biotech company founded in 2024 and based in Bron, close to Lyon, France. Our team is committed to transform scientific discoveries into adapted therapeutic solutions for patients. More about us and our team. GAOMA is a biotech company founded in 2024 and based in Bron, close to Lyon, … GAOMA Therapeutics is headquartered within the European Institute for … GAOMA Therapeutics is a pharmaceutical company developing a unique portfolio … Leadership team. Our leadership team brings together broad and … This is why GAOMA’s Strategic Committee gathers members with strong and … This is why GAOMA brought together advisors with complementary expertise. … GAOMA is a biotech company founded in 2024 and based in Bron, close to Lyon, … Epilepsy is the first targeted indication with GAOMA’s lead drug candidate GAO-3 … Among its portfolio of active ingredients, GAOMA Therapeutics identified a first … GAO-3-02 is a novel active ingredient developed by GAOMA Therapeutics. … WebDec 20, 2024 · gaoma-therapeutics.com was created on Dec 20, 2024. A website for this domain is hosted in France, according to the geolocation of its IP address 213.186.33.5. rake cprWebGaoma Therapeutics . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 22. About. Gaoma Therapeutics is actively using 22 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and SPF. dr godinez laredo tx

"WebGAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under ... " - Gaoma therapeutics logo

Gaoma therapeutics logo

WebGaoma Therapeutics is a biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases. The company’s initial medicine candidate, GAO-3-02, is a novel proprietary active component. Gaoma Therapeutics specializes in epilepsy … WebApr 1, 2024 · Gaoma Therapeutics General Information. Description. Developer of therapeutic molecule intended to address unmet medical needs in neurological or inflammatory diseases. The company offers particular expertise in the fields of epilepsy and cognitive disorders and offers a portfolio of innovative lipids derivatives as drug …

Did you know?

WebApr 1, 2024 · Alzheimer's disease is a progressive, degenerative condition causing damage to memory and behavior due to the attack on the neurons. The Alzheimer’s Disease Drugs in Development market report provides an overview of the Alzheimer’s Disease pipeline landscape. The report provides comprehensive information on the therapeutics under … WebGAOMA Therapeutics announces its first capital increase and a strategic partnership with the PPRS Group, for the development of its first-in-class drug-candidate GAO-3-02. This oversubscribed fund raising reaches a total equity investment over € 1.1m. The life sciences Business Angels organizations

WebGAO-3-02. GAO-3-02 is a novel active ingredient developed by GAOMA Therapeutics. Thanks to its innovative mode of action, this lipid derivative represents a promising drug candidate for epilepsy. Targeting primarily the protection or restoration of cognitive functions in epilepsy, GAO-3-02 has also shown in various preclinical studies a strong ... WebMar 24, 2024 · The PTC Therapeutics logo is pictured on a phone screen/courtesy of SOPA Images/Getty Images. England’s National Institute for Health and Care Excellence (NICE) has recommended PTC Therapeutics’ Upstaza (eladocagene exuparvovec) for …

WebGAOMA Therapeutics is a biotech company established early 2024 in Lyon, France, to develop pioneering drugs for neurological and inflammatory disorders, and more specifically for epilepsy and its associated comorbidities. The original scientific project arose from the academic research group TIGER (Translational and Integrative Group in ...

WebReach decision-makers at GAOMA Therapeutics. Find their phone numbers & email addresses. It’s free. - Lusha

WebNov 29, 2024 · -- Lengo Therapeutics to be acquired for $250 million in cash plus $215 million in future potential payments based on the achievement of certain approval and sales-based milestones dr godinezWebAmong its portfolio of active ingredients, GAOMA Therapeutics identified a first lead compound referred to as GAO-3-02. Home Company overview Leadership team Strategy Advisory Board Partners & Institutions Therapeutic Areas Therapeutic Approach … rake crushWebApr 14, 2024 · Gaoma Therapeutics has raised a total of €1.1M in funding over 1 round. This was a Seed round raised on Apr 14, 2024. Gaoma Therapeutics is funded by 4 investors. Angels Santé and PPRS Venture are the most recent investors. dr godinez laredoWebCompanies like Gaoma Therapeutics include Monte Rosa Therapeutics, Remix Therapeutics, and Vigil Neuroscience. Cedilla Therapeutics . Cambridge, Massachusetts, United States 40 Contacts 1-10 employees . Biotechnology. Health Care. Therapeutics. dr godin audicWebGAOMA Therapeutics is headquartered within the European Institute for Epilepsies (IDEE), which is located on the East hospital complex of Lyon. Home Company overview Leadership team Strategy Advisory Board Partners & Institutions Therapeutic Areas Therapeutic Approach Innovative Lipid Vectors Pipeline GAO-3-02 / GAO-11-02 News Contact. dr godinez audiologyWebAmong its portfolio of active ingredients, GAOMA Therapeutics identified a first lead compound referred to as GAO-3-02. Home Company overview Leadership team Strategy Advisory Board Partners & Institutions Therapeutic Areas Therapeutic Approach Innovative Lipid Vectors Pipeline GAO-3-02 / GAO-11-02 News Contact rake crgslistWebGaoma Therapeutics is a biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases. rake costume